MIAMI--(BUSINESS WIRE)--May 2, 2005--IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that it received final approval on April 29, 2005 from the U.S. Food and Drug Administration (FDA ...
Litigation continues, but Ivax Corp. said it has regulatory permissions in place for its launch of additional generic versions of a Pfizer anti-seizure tablet. The Miami-based drug maker said its ...
Pfizer (New York, NY, www.pfizer.com) has voluntarily recalled one lot (40,000 bottles) of its epilepsy medication "Neurontin." According to the company, a manufacturing mechanical failure resulted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results